Defining response to anti-VEGF therapies in neovascular AMD – (Eye 29, 1397 (October 2015))
Defining response to anti-VEGF therapies in neovascular AMD Eye 29, 1397 (October 2015). doi:10.1038/eye.2015.159 Authors: W M Amoaku, U Chakravarthy, R Gale, M Gavin, F Ghanchi, J Gibson, S Harding, R L Johnston, S P Kelly, A Lotery, S Mahmood, G Menon, S Sivaprasad, J Talks, A Tufail & Y Yang
New ideas for glaucoma – (Eye 29, 1241 (October 2015))
New ideas for glaucoma Eye 29, 1241 (October 2015). doi:10.1038/eye.2015.153 Author: A Lotery
Vision-related quality of life, metamorphopsia, and stereopsis after successful surgery for rhegmatogenous retinal detachment – (Eye Journal AOP)
Vision-related quality of life, metamorphopsia, and stereopsis after successful surgery for rhegmatogenous retinal detachment Eye advance online publication, October 2 2015. doi:10.1038/eye.2015.171 Authors: G Lina, Q Xuemin, W Qinmei & S Lijun
Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy – (Eye Journal AOP)
Conservative treatment of retinoblastoma: a prospective phase II randomized trial of neoadjuvant chemotherapy followed by local treatments and chemothermotherapy Eye advance online publication, October 2 2015. doi:10.1038/eye.2015.179 Authors: L Lumbroso-Le Rouic, I Aerts, D Hajage, C Lévy-Gabriel, A Savignoni, N Algret, N Cassoux, A-I Bertozzi, M Esteve, F Doz & L Desjardins
Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma – (Eye Journal AOP)
Evaluation the adjunctive use of combined bevacizumab and mitomycinc to trabeculectomy in management of recurrent pediatric glaucoma Eye advance online publication, October 2 2015. doi:10.1038/eye.2015.182 Authors: R A Mahdy, S M Al-Mosallamy, M A Al-Aswad, A Bor’i & W M El-Haig